About DNTOX
DNTOX is a Chemicals & Materials company based in Dusseldorf (Germany) founded in 2022 by Katharina Koch and Kristina Bartmann. Chemical testing and development services are provided by DNTOX. DNTOX has raised $1.53 million across 1 funding round from investors including High-Tech Gründerfonds, Bool Capital and AQAL. DNTOX offers products and services including Developmental Neurotoxicity Testing and Adult Neurotoxicity Testing. Its focus areas include Chemicals and Materials and Chemical Services. Its legal entity is DNTOX GmbH.
Company details
DNTOX was founded in 2022 in Dusseldorf, Germany, by co-founders Katharina Koch and Kristina Bartmann. Operations focus on the chemical sector, where testing and development services are delivered to clients. The company maintains a presence through its domain dntox.de, supporting activities in chemical analysis and innovation within the European market. Services encompass various testing protocols and developmental processes tailored to industry needs.
- Total Equity Funding$1.53M (USD)
in 1 rounds
- Latest Funding Round$1.53M (USD), Seed
Jun 2023
- InvestorsHigh-Tech Gründerfonds
& 2 more
Products & Services of DNTOX
DNTOX offers a comprehensive portfolio of products and services, including Developmental Neurotoxicity Testing and Adult Neurotoxicity Testing.
Chemicals are evaluated for potential disturbances in brain development using multicellular and multiplexed human-based 2D/3D in vitro systems.
Compounds are assessed for neurotoxicity effects through 3D hiPSC-derived BrainSpheres on multi-electrode arrays to identify neurotransmitter receptor subtypes.
Funding Insights of DNTOX
DNTOX has successfully raised a total of $1.53M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.53 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.53M
- Total Rounds 1
- Last Round Seed — $1.53M
- First Round $1.53M
(Jun 2023)
- Investors Count 3
All 1 funding rounds of DNTOX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2023 | $1.53M | Seed | – | HTGF |
3 investors in total: 3 institutional.
Investors in DNTOX
DNTOX has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include High-Tech Gründerfonds, Bool Capital and AQAL.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in high-tech startups by HTGF. | htgf.de | Bonn, Germany | ||
| bool.capital | ||||
AQAL is engaged in integral investing for sustainable prosperity. | aqalgroup.com | Munich, Germany |
Investor details for DNTOX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DNTOX
2 people are tracked at DNTOX (2 in leadership).
| Name | Role | Group |
|---|---|---|
Katharina Koch | Co-Founder | Leadership |
Kristina Bartmann | Co-Founder | Leadership |
Complete people profiles for DNTOX
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DNTOX
2 dated milestones of DNTOX across 1 years, from founding to its latest funding, stage changes and deals.
- Founded DNTOX is founded.
- Funding First funding round of $1.5M.
Web traffic of DNTOX
The website of DNTOX (dntox.de) receives about 2.1K visits a month.
- Monthly visits2.1K
▼ 67.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DNTOX
DNTOX was founded in 2022 and raised its 1st funding round 1 year after it was founded.
DNTOX is headquartered in Dusseldorf, Germany. It is registered at Dusseldorf, North Rhine-westphalia, Germany.
DNTOX is a funded company, having raised a total of $1.53M across 1 funding round to date. The company's 1st funding round was a Seed of $1.53M, raised on Jun 2023.
DNTOX was founded in 2022 in Dusseldorf, Germany, by co-founders Katharina Koch and Kristina Bartmann. Operations focus on the chemical sector, where testing and development services are delivered to clients. The company maintains a presence through its domain dntox.de, supporting activities in chemical analysis and innovation within the European market. Services encompass various testing protocols and developmental processes tailored to industry needs.
DNTOX offers Developmental Neurotoxicity Testing and Adult Neurotoxicity Testing.
DNTOX has 3 investors. Key investors include High-Tech Gründerfonds, Bool Capital, and AQAL.
DNTOX operates through Dntox Gmbh.